הפרין 2 יחב"ל/מ"ל & % 0.9 סודיום כלוריד ישראל - עברית - Ministry of Health

הפרין 2 יחב"ל/מ"ל & % 0.9 סודיום כלוריד

neopharm (israel) 1996 ltd - heparin sodium 200 iu / 100 ml - solution for injection - heparin - as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

פרופס ישראל - עברית - Ministry of Health

פרופס

ferring pharmaceuticals ltd - dinoprostone - התקן תוך נרתיקי - dinoprostone 10 mg - dinoprostone - dinoprostone - initiation and/or continuation of cervical ripening in patients at term, from 38th week of gestation, with bishop score of 6 or less.

נורפרולק 0.025 מג ישראל - עברית - Ministry of Health

נורפרולק 0.025 מג

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.025 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

נורפרולק 0.05 מג ישראל - עברית - Ministry of Health

נורפרולק 0.05 מג

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.05 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

נורפרולק 0.075 מג טבליות ישראל - עברית - Ministry of Health

נורפרולק 0.075 מג טבליות

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.075 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

נורפרולק 0.15 מג טבליות ישראל - עברית - Ministry of Health

נורפרולק 0.15 מג טבליות

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.15 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

אטוסיבן - פרינג ישראל - עברית - Ministry of Health

אטוסיבן - פרינג

ferring pharmaceuticals ltd - atosiban - solution for injection - atosiban 7.5 mg/ml - atosiban - atosiban - atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.

מנופור מולטידוז 600 IU ישראל - עברית - Ministry of Health

מנופור מולטידוז 600 iu

ferring pharmaceuticals ltd - menotrophin - אבקה וממס להכנת תמיסה להזרקה - menotrophin 600 iu - human menopausal gonadotrophin - human menopausal gonadotrophin - sterility in females with hypo or normogonadotropic ovarian insufficiency : stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism: in combination with hcg to spermatogenesis.

מנופור מולטידוז 1200 IU ישראל - עברית - Ministry of Health

מנופור מולטידוז 1200 iu

ferring pharmaceuticals ltd - menotrophin - אבקה וממס להכנת תמיסה להזרקה - menotrophin 1200 iu - human menopausal gonadotrophin - human menopausal gonadotrophin - sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism: in combination with hcg to spermatogenesis

ברבל ישראל - עברית - Ministry of Health

ברבל

ferring pharmaceuticals ltd - urofollitrophin highly purified (hpfsh) 75 iu/vial - powder for solution for injection - urofollitropin - anovulation (including polycystis ovarian disease (pcod) in women who have been unresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (evf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).